- At BIO, tension over China biotech deal regulation looms<figure><div><img src="https://imgproxy.divecdn.com/QMMgdLWmV9_RV75ozi_JOVMqLcnMq3yXkrVCs0nJ7_U/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTgyOTQ2OTI4LmpwZ…BioPharma Dive · 1mo ago↗ source
- Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda<p>Blair Jackson says the next 12 months may be the most important in Alkermes’ history, as the brain drugmaker races to join an “orexin” market that analysts see as a multibillio…BioPharma Dive · 1mo ago↗ source
- On second try, Acadia drug gets nod from European regulators<figure><div><img src="https://imgproxy.divecdn.com/HqB6XqxuaD9NspfVrU6NR4gdT5eCkfyQMHS0wCYOdwk/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjU1OTk4NTE0LmpwZ…